GSK plc (GSK) income statement
GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 9/30
$47.82−0.76 (-1.56%)
Close on Nov 19, 2026Market cap $103.18BP/E 13.0Yield –
GSK plc income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 72.4%
- Operating margin
- 24.3%
- Net margin
- 17.5%
- Return on equity, FY2025
- 38.0%
Financial strength
- Current ratio
- 0.82
- Debt to equity
- 1.08
- Debt to assets
- 29.0%
- Cash to current liabilities
- 15.9%
Valuation
- P/E ratio
- 13.0
- Price to sales
- 2.39
- Price to book
- 4.77
- Dividend yield
- –
See a number that looks wrong?